Skip to main content
. 2019 Dec 2;8:e51662. doi: 10.7554/eLife.51662

Table 1. CRISPR/Cas9 target sequences.

Name Efficiency of cleavage SaCas9 sgRNA + PAM
(g was added as needed)
Target sequences
(GenBank: KT899744)
UL30
UL30-1 + GCGTCCCGACTGGGGCGAGGT AGGGGT 62811–62831
UL30-2 ++ gAAGTTTTGCCTCAAACAAGGC GGGGGT 62779–62799
UL30-3 - GCGGCGTGGACCACGCCCCGG CGGGGT 63060–63080
UL30-4 ++ gTGCCCCCCCGGAGAAGCGCG CCGGGGT 62923–62942
UL30-5 ++ gACACGTGAAAGACGGTGACG GTGGGGT 63097–63116
UL30-6 + gACCAGCCGAAGGTGACGAAC CCGGGGT 63595–63614
UL30-7 ++ GGCCATCAAGAAGTACGAGGG TGGGGT 63532–63552
UL30-24* ++ gAAACCCCAAAAGCCGCTTGGG TGGGAT 62589–62609
UL30-25* + gCCACCCGAACCCCTAAAGAGG GGGGAT 62637–62657
UL30-26* - gCATGCCGGCCCGGGCGAGCCT GGGGGT 62542–62562
UL30-27* ++ gCCATCCCACCCAAGCGGCTTT TGGGGT 62581–62601
UL29
UL29-1 ++ gTCAAGGTCCCCCCCGGGCCCC TGGGAT 61861–61881
UL29-2 + GTGTTTGAGGTCGCCGGGCCG GGGGGT 61502–61522
UL29-3 ++ GCCAGCCAGGGTAAGACCCCG CGGGGT 61028–61048
UL29-4 ++ GCCGCCGTCGCGCCCACCCCG CGGGGT 61007–61027
UL29-14* ++ GAGGGTGGGAGACCGGGGTTG GGGAAT 62029–62049
UL29-15* ++ GTCGGGCGTCCGTCGTCGTGC CGGGAT 61952–61972
UL29-16* ++ gCGGGGGTTGTCTGTGAAGGGT AGGGAT 62064–62084
UL29-17* ++ gATCGGCACCCCGTGGTTACCC GGGGGT 62084–62104
UL29-18* ++ gCAGACAACCCCCGGGTAACCA CGGGGT 62072–62092
UL29-19* ++ GGACCCCGCGTTGCCAGCCGC CGGGGT 62113–62133
UL29-20* ++ GAACCCCGGCGGCTGGCAACG CGGGGT 62105–62125
UL29- 21 ++ GGTTCTCGCACGACGGGGCTC GGGGGT 61685–61705
UL54
UL54-1* ++ GCTGTCGGCTGCCGTCGGGGC TGGGGT 113541–113561
UL54-2 ++ gACCTGGAATCGGACAGCAAC GGGGAGT 113667–113687
UL54-3 ++ GCTCCGGTCCGTCCTCTCCGT GGGGGT 113728–113748
UL54-4 ++ GCGTCTGGGTGCTGGGTACGC CGGGGT 113803–113823
UL54-5 ++ GGCGGACGCCGTGGGCGTCGC AGGGGT 113982–114002
UL54-6 ++ gTGGTTCTGGGGGCACGCCGGC GGGGGT 114055–114075
UL54-7 ++ GCAGGCTGGGCTTTGGTCGGT GGGGGT 113957–113977
UL54-8 ++ gCGCCGTGGGCGTCGCAGGGGT CGGGGT 113988–114008
UL54-9 + GTCCGTCCACCCCGCCCCGGGG CGGGGT 114098–114119
UL54-14* ++ gCGCTTCCGCGGGGACCCGGGC GGGGGT 113234–113254
UL54-15* ++ gCGCCCGGGGGGCGGAACTAGG AGGGGT 113347–113367
UL54-16 ++ GGCGGCTCTCCGCCGGCTCGG GGGGGT 113641–113661
Rs1
Rs1-1 ++ GCCGGGCGTCGTCGAGGTCGT GGGGGT 130775–130795, 146992–147012
Rs1-2 - gCCGCTCGTCGCGGTCTGGGCT CGGGGT 130866–130886, 146901–146921
Rs1-3 - GGGGGTGGTCGGGGTCGTGGT CGGGGT 130796–130816, 146971–146991
Rs1-4 ++ gATCGTCGTCGGCTAGAAAGGC GGGGGT 130599–130619, 147168–147188
Rs1-5 ++ GGCGCGGCGACAGGCGGTCCG TGGGGT 130475–130495, 147292–147312
Rs1-6 ++ GCGAGGCCGCGGGGTCGGGCGT CGGGAT 130634–130655, 147132–147153
Rs1-7 + GGGTCCGGGGCGGCGAGGCCG CGGGGT 130622–130642, 147145–147165
Rs1-8 ++ gCGCGAGGCGCGGGCCGTCGGG CGGGGT 130290–130310, 147477–147497
Rs1-9 ++ GCGGACGACGAGGACGAGGACC CGGAGT 130378–130399, 147388–147409
Rs1-15* ++ GCCGATGCGGGGCGATCCTCC GGGGAT 130954–130974, 146813–146833
Rs1-16* - gTACGCGGACGAAGCGCGGGAG GGGGAT 131142–131162, 146625–146645
Rs1-17* + gCGCGTCGACGGCGGGGGTCGT CGGGGT 131061–131081, 146706–146726
Rs1-18* ++ GCGCTAGTTCCGCGTCGACGGC GGGGGT 131070–131091, 146696–146717
UL26-27 ++ GAGGAAATCGGCACTGACCAA GGGGGT 52742–52762
UL37-38 ++ GTATAACACCCCGCGAAGACG CGGGGT 84066–84086

++:full cleavage (no residual substrate DNA on agarose gel), +: partial cleavage (some residual substrate DNA on agarose gel), -: no cleavage, *: non-coding region.